Outlook Therapeutics (41O) Short Interest
DB • 41O • US69012T3059
As of Oct 27, 2026, ORTEX estimated 1.6% of free float sold short, 574.8 days to cover, cost to borrow 3.44%. Sign up for live short interest data.
DB • 41O • US69012T3059
As of Oct 27, 2026, ORTEX estimated 1.6% of free float sold short, 574.8 days to cover, cost to borrow 3.44%. Sign up for live short interest data.
This page tracks how heavily Outlook Therapeutics (DB:41O) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Outlook Therapeutics (DB: 41O) has a market capitalization of $117.1M. Last close €0.40 (as of 2026-11-12); 52-week range €0.15 to €2.26. ORTEX data as of 2026-10-27: short interest was 1.64% of free float, 574.8 days to cover and the average cost to borrow was 3.44%. Sign up for live short interest data.